Frequent use of antibiotics may increase the risk of inflammatory bowel disease (IBD) among the over 40s, new research suggests. The risk appears to be cumulative,...
The US Food and Drug Administration (FDA) has approved lecanemab – a breakthrough drug for patients in the earliest stages of Alzheimer’s disease. Developed by Japanese...
The Naborforce platform connects older adults with kind-hearted community members.
The project explored the daily experiences and challenges of those with dementia
Europe’s largest provider of digital-first home healthcare, Cera, is further investing in its technology and data insights as winter approaches. Cera, a digital-first home healthcare company...
With the right infrastructure in place, patients can now receive high-quality, safe, hospital-level care in the comfort of their homes.
The e-learning platform has partnered with Washington State University to provide free education.
A new drug appears to slow Alzheimer’s disease in what experts defined a “historic moment”. A new drug called lecanemab, has been developed by pharmaceutical companies...
Age UK has launched a new programme to help older people stay connected online. Age UK has launched a £5 million digital campaign programme, which aims...
“We hope to harness the power of light to relieve the suffering that millions of Alzheimer’s disease patients and their loved ones experience every day.”
